Advertisement

ADVERTISEMENT

Interventional oncology

Efficacy of Feraheme as Lymphatic Contrast Agent in Prostate Cancer
04/12/2018
CIO included several featured abstracts, and we had the opportunity to talk in more detail with one of the authors. Authors: M.J. Dattoli, S.M. Bravo, D.M. Kaplon, M. Hayes, A. Osorio, P.M. Dycus, D. Bostwick, J.M. Kaminski Why did you...
CIO included several featured abstracts, and we had the opportunity to talk in more detail with one of the authors. Authors: M.J. Dattoli, S.M. Bravo, D.M. Kaplon, M. Hayes, A. Osorio, P.M. Dycus, D. Bostwick, J.M. Kaminski Why did you...
CIO included several featured...
04/12/2018
IO Learning
Why Biopsy Is the Key to Personalized Medicine
03/29/2018
Biopsy is the foundation of cancer care, but its importance is often understated. As the framework of precision medicine becomes more ingrained in the standard of care, interventional radiologists must remain well versed on the latest...
Biopsy is the foundation of cancer care, but its importance is often understated. As the framework of precision medicine becomes more ingrained in the standard of care, interventional radiologists must remain well versed on the latest...
Biopsy is the foundation of...
03/29/2018
IO Learning
News
Is Percutaneous Thermal Ablation Safe and Effective for Hepatocellular Adenomas?
02/23/2018
Percutaneous thermal ablation for hepatocellular adenomas is safe and effective, according to a study published in Cardiovascular and Interventional Radiology. Hepatocelluar adenomas are benign neoplasms, though they pose a risk of...
Percutaneous thermal ablation for hepatocellular adenomas is safe and effective, according to a study published in Cardiovascular and Interventional Radiology. Hepatocelluar adenomas are benign neoplasms, though they pose a risk of...
Percutaneous thermal ablation...
02/23/2018
IO Learning
Tumor Necrosis in Conventional Versus Drug-Eluting Bead Transarterial Chemoembolization for HCC
02/22/2018
CIO included several featured abstracts, and we had the opportunity to talk in more detail with the authors. Abstract authors: E. Fayazzadeh, A.H. Amer, F. Aucejo, G. McLennan What sparked your interest in comparing outcomes of conventional...
CIO included several featured abstracts, and we had the opportunity to talk in more detail with the authors. Abstract authors: E. Fayazzadeh, A.H. Amer, F. Aucejo, G. McLennan What sparked your interest in comparing outcomes of conventional...
CIO included several featured...
02/22/2018
IO Learning
News
Glass vs Resin Microspheres for Intrahepatic Cholangiocarcinoma
02/20/2018
Patients with intrahepatic cholangiocarcinoma (ICC) may receive a higher dose to the targeted tumors if Y90 glass microspheres are used rather than resin-based microspheres, researchers reported. In this retrospective study, researchers...
Patients with intrahepatic cholangiocarcinoma (ICC) may receive a higher dose to the targeted tumors if Y90 glass microspheres are used rather than resin-based microspheres, researchers reported. In this retrospective study, researchers...
Patients with intrahepatic...
02/20/2018
IO Learning
Immunotherapy and Image-Guided Therapy: Are There Synergies?
01/11/2018
Immunotherapy is revolutionizing cancer care, and its success has led interventionalists to wonder how it might pair with image-guided therapy in the future. Despite some concerns in the field that immunotherapy might replace image-guided...
Immunotherapy is revolutionizing cancer care, and its success has led interventionalists to wonder how it might pair with image-guided therapy in the future. Despite some concerns in the field that immunotherapy might replace image-guided...
Immunotherapy is revolutionizing...
01/11/2018
IO Learning
News
Transradial vs Transfemoral Access for Chemoembolization: Which Is Safer?
09/18/2017
The transradial approach appears to allow safe access and is feasible in patients undergoing hepatic chemoembolization, researchers reported in the Journal of Vascular and Interventional Radiology. Although the transradial approach is often...
The transradial approach appears to allow safe access and is feasible in patients undergoing hepatic chemoembolization, researchers reported in the Journal of Vascular and Interventional Radiology. Although the transradial approach is often...
The transradial approach appears...
09/18/2017
IO Learning
News
Guideline Issued for Quality Improvement in TACE and Embolization of Hepatic Malignancy
09/07/2017
The Society of Interventional Radiology (SIR) has published a quality improvement guideline for transarterial chemoembolization and embolization of hepatic malignancy. The guideline was developed via a literature search, followed by critical...
The Society of Interventional Radiology (SIR) has published a quality improvement guideline for transarterial chemoembolization and embolization of hepatic malignancy. The guideline was developed via a literature search, followed by critical...
The Society of Interventional...
09/07/2017
IO Learning
News
Y90 Radioembolization Shows Promise for Treating Combined Hepatocellular-Cholangiocarcinoma
08/31/2017
Transarterial radioembolization with yttrium-90 (Y90) microspheres shows promise as a safe, effective treatment for patients with unresectable combined hepatocellular-cholangiocarcinoma (cHCC-CC), a rare and aggressive form of primary liver...
Transarterial radioembolization with yttrium-90 (Y90) microspheres shows promise as a safe, effective treatment for patients with unresectable combined hepatocellular-cholangiocarcinoma (cHCC-CC), a rare and aggressive form of primary liver...
Transarterial radioembolization...
08/31/2017
IO Learning
News
Radioembolization: Finding Patients Who Will Benefit Most in “Bridge-to-Resection” Setting
08/22/2017
Younger patients with compensated cirrhosis may be best suited to benefit from radioembolization in a “bridge-to-resection” setting, according to PLoS One. In this retrospective study, researchers sought to determine which factors are linked...
Younger patients with compensated cirrhosis may be best suited to benefit from radioembolization in a “bridge-to-resection” setting, according to PLoS One. In this retrospective study, researchers sought to determine which factors are linked...
Younger patients with...
08/22/2017
IO Learning

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

September 18 ⁠–⁠ September 20
September 20 ⁠–⁠ September 22
September 21 ⁠–⁠ September 22
AMP Europe
September 30 ⁠–⁠ October 2
October 1 ⁠–⁠ October 2
SAWC Fall
October 2 ⁠–⁠ October 5
October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use